Nycomed Q310 Results Highlight The Company's Focus On Emerging Markets

BMI View: Nycomed's Q310 results reinforce our view that emerging markets will drive industry growth. The company's sales in Western Europe declined by 5.5% in Q310. Contrastingly, sales in Latin America posted a double-digit growth of 36.6%, sales in Russia/CIS posted growth of 50.2% and sales in Asia Pacific, the Middle East and Africa posted a collective growth of 30.6% in the same quarter

To read the full article, please choose one of the following options: